ducovest

FHH:CA:TSX-First Trust AlphaDEX US Health Care (CAD)

ETF | Sector Equity |

Last Closing

CAD 43.57

Change

0.00 (0.00)%

Market Cap

CAD 0.01B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Currency: CAD

Country : Canada

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-02 )

Largest Industry Peers for Sector Equity

Symbol Name Price(Change) Market Cap
TEC:CA TD Global Technology Leaders I..

N/A

 CAD 3.39B
ZWU:CA BMO Covered Call Utilities ETF

N/A

 CAD 1.82B
XIT:CA iShares S&P/TSX Capped Informa..

N/A

 CAD 0.78B
TXF:CA First Asset Tech Giants Covere..

N/A

 CAD 0.66B
HTA:CA Harvest Tech Achievers Growth ..

N/A

 CAD 0.65B
XHC:CA iShares Global Healthcare (CAD..

N/A

 CAD 0.54B
ZUT:CA BMO Equal Weight Utilities Ind..

N/A

 CAD 0.51B
XUT:CA iShares S&P/TSX Capped Utiliti..

N/A

 CAD 0.40B
CWW:CA iShares Global Water Common Cl..

N/A

 CAD 0.30B
COW:CA iShares Global Agriculture Com..

N/A

 CAD 0.28B

ETFs Containing FHH:CA

FSR:CA First Trust Morningstar D.. 0.00 % 1.10 %

N/A

 N/A

Market Performance

  Market Performance vs. Industry/Classification (Sector Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 8.38% 97% N/A 90% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.38% 97% N/A 89% A-
Trailing 12 Months  
Capital Gain 16.84% 69% C- 63% D
Dividend Return 0.24% 16% F 3% F
Total Return 17.08% 63% D 56% F
Trailing 5 Years  
Capital Gain 43.80% 54% F 68% D+
Dividend Return 8.60% 41% F 18% F
Total Return 52.39% 49% F 62% D
Average Annual (5 Year Horizon)  
Capital Gain 4.96% 40% F 50% F
Dividend Return 4.99% 34% F 44% F
Total Return 0.03% 6% D- 2% F
Risk Return Profile  
Volatility (Standard Deviation) 11.56% 74% C 69% C-
Risk Adjusted Return 43.14% 40% F 54% F
Market Capitalization 0.01B 9% A- 8% B-

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.